MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Medical to Acquire Controlling Stake in Dragonbio’s Orthopedics Business for US$35.5 million SHENZHEN, China, June 6, 2012 /PRNewswire-Asia-FirstCall/ — Mindray Medical International Limited (NYSE:MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today a definitive agreement to acquire a controlling stake of Wuhan Dragonbio Surgical Implant Co., Ltd. (“Dragonbio”), a domestic medical orthopedic products provider that]

MR [Mindray Medical International] 6-K: Mindray Medical to Acquire Controlling Stake in Dragonbio’s

[Mindray Medical to Acquire Controlling Stake in Dragonbio’s Orthopedics Business for US$35.5 million SHENZHEN, China, June 6, 2012 /PRNewswire-Asia-FirstCall/ — Mindray Medical International Limited (NYSE:MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today a definitive agreement to acquire a controlling stake of Wuhan Dragonbio Surgical Implant Co., Ltd. (“Dragonbio”), a domestic medical orthopedic products provider that]

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Medical to Acquirentrolling Stake in Dragonbios Orthopedics Business for US$35.5 million STYLE="font-family:Times New Roman" SIZE="2"> STYLE="font-family:Times New Roman" SIZE="2">SHENZHEN, China, June6, 2012 /PRNewswire-Asia-FirstCall/ Mindray Medical International Limited (NYSE:MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today a definitivereement to acquire antrolling stake of Wuhan Dragonbio Surgical Implant (Dragonbio), a domestic]

MR [Mindray Medical International] 6-K: Mindray Medical to Acquirentrolling Stake in Dragonbios Orthopedics

[Mindray Medical to Acquirentrolling Stake in Dragonbios Orthopedics Business for US$35.5 million STYLE="font-family:Times New Roman" SIZE="2"> STYLE="font-family:Times New Roman" SIZE="2">SHENZHEN, China, June6, 2012 /PRNewswire-Asia-FirstCall/ Mindray Medical International Limited (NYSE:MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today a definitivereement to acquire antrolling stake of Wuhan Dragonbio Surgical Implant (Dragonbio), a domestic]

VIPS [Vipshop] 6-K: Vipshop Holdings Limited By : Donghao Yang Chief

[Vipshop Holdings Limited By : Donghao Yang Chief Financial Officer 2 3 Vipshop Appoints Chief Technology Officer Guangzhou, China, June 5, 2012 – Vipshop Holdings Limited (NYSE: VIPS), China’s leading online discount retailer for brands (“Vipshop” or the “Company”), today announced the appointment of Mr. Daniel Kao as the Company’s Chief Technology Officer (“CTO”). Mr. Kao has more than sixteen]

By | 2016-03-12T23:28:00+00:00 June 6th, 2012|Categories: Chinese Stocks, VIPS, Webplus ver|Tags: , , , , , |0 Comments

KUTV [Ku6 Media] 6-K: (Original Filing)

[Ku6 Media Reports Unaudited Financial Results for the First Quarter of Fiscal Year 2012 BEIJING, China, June 5, 2012 — Ku6 Media Co., Ltd. (“Ku6 Media” or the “Company”, NASDAQ: KUTV) , a leading internet video company in China, focusing on User Generated Content (“UGC”), today announced unaudited financial results for the first quarter of fiscal year 2012, ended March]

By | 2016-03-13T01:34:43+00:00 June 6th, 2012|Categories: Chinese Stocks, KUTV, SEC Original|Tags: , , , , , |0 Comments

KUTV [Ku6 Media] 6-K: Ku6 Media Reports Unaudited Financial Results for the

[Ku6 Media Reports Unaudited Financial Results for the First Quarter of Fiscal Year 2012 BEIJING, China, June 5, 2012 — Ku6 Media Co., Ltd. (“Ku6 Media” or the “Company”, NASDAQ: KUTV) , a leading internet video company in China, focusing on User Generated Content (“UGC”), today announced unaudited financial results for the first quarter of fiscal year 2012, ended March]

By | 2016-03-13T01:37:23+00:00 June 6th, 2012|Categories: Chinese Stocks, KUTV, Webplus ver|Tags: , , , , , |0 Comments

TPI [TIANYIN PHARMACEUTICAL] 8-K: (Original Filing)

[Consulting Agreement This agreement (the “Agreement”) dated and effective this 4th day of June, 2012 by and between Tianyin Pharmaceutical Co., Inc, a Delaware corporation (“TPI” or the “Company”), and James T. McCubbin (“Consultant”). Recitals I. TPI desires to obtain consulting and advisory services from Consultant. II. Consultant, on a part time basis, is in the business of providing such] [INDEPENDENT DIRECTOR AGREEMENT OF TIANYIN PHARMACEUTICAL CO., INC. , This INDEPENDENT DIRECTOR AGREEMENT (the “Agreement”) is made and entered into as of this 4th day of June, 2012 (the “Effective Date”), by and between Tianyin Pharmaceutical Co., Inc. WHEREAS, the Company desires to engage the Independent Director, and the Independent Director desires to serve, as a non-employee director of the] [CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT June 4, 2012 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 o o o]

By | 2016-03-27T19:22:55+00:00 June 6th, 2012|Categories: Chinese Stocks, SEC Original, TPI|Tags: , , , , , |0 Comments

TPI [TIANYIN PHARMACEUTICAL] 8-K: Consulting Agreement This agreement (the “Agreement”) dated and

[Consulting Agreement This agreement (the “Agreement”) dated and effective this 4th day of June, 2012 by and between Tianyin Pharmaceutical Co., Inc, a Delaware corporation (“TPI” or the “Company”), and James T. McCubbin (“Consultant”). Recitals I. TPI desires to obtain consulting and advisory services from Consultant. II. Consultant, on a part time basis, is in the business of providing such] [INDEPENDENT DIRECTOR AGREEMENT OF TIANYIN PHARMACEUTICAL CO., INC. , This INDEPENDENT DIRECTOR AGREEMENT (the “Agreement”) is made and entered into as of this 4th day of June, 2012 (the “Effective Date”), by and between Tianyin Pharmaceutical Co., Inc. WHEREAS, the Company desires to engage the Independent Director, and the Independent Director desires to serve, as a non-employee director of the] [CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT June 4, 2012 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 o o o]

By | 2016-03-27T19:23:47+00:00 June 6th, 2012|Categories: Chinese Stocks, TPI, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar